Aphena Pharma Solutions Inc. is investing in a $7 million company-wide expansion for future growth opportunities to be completed by the end of 2019. Targeted expansion areas include additional manufacturing space, custom blending suites, new liquid blending vessels and an additional high-speed bottling line.
 
“As Aphena continues our path towards healthcare contract service excellence and innovation, we are committed to investing in our customers’ future and earning our place as their preferred and trusted partner,” said Aphena chief executive officer, Shawn Reilley.
 
The expansion includes: two additional large pharmaceutical blending suites with separate air handling systems in the company’s manufacturing facility in Maryland; two tri-mix blending tanks with counter-rotating sweep and high-shear mixing with vacuum to handle small and large batching for specialty creams, gels and topical products; a 30,000-sq.-ft. expansion of the Tennessee facility; and an additional high-speed, fully-automated bottling line with serialization in the company’s Tennessee facility to support both over-the-counter (OTC) and prescription products.
 
“These planned expansions at our Maryland and Tennessee facilitieswill position Aphena to support significant future growth,” said Aphena chief operating officer, Bob Scott. “We are committed to investing aggressively as needed to ensure that Aphena remains an industry leader in terms of innovation and turnaround time.”
 
Aphena provides contract packaging and manufacturing services for the pharmaceutical, consumer health and medical device markets. The company has two FDA- and DEA-registered sites in the U.S. that handle solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions.